Connect the dots...Put on your tin foil hat, but this is probably why Ivermectin is having trouble gaining acceptance in the U.S. Good idea for MVMD to target the international market first.
https://www.bloomberg.com/news/features/2021-03-25/merck-mrk-molnupiravir-pill-could-change-the-fight-against-covid?srnd=businessweek-v2